SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-15-040615
Filing Date
2015-02-10
Accepted
2015-02-10 10:21:35
Documents
5
Period of Report
2015-02-04
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d869071d8k.htm 8-K 19673
2 EX-1.1 d869071dex11.htm EX-1.1 185653
3 EX-5.1 d869071dex51.htm EX-5.1 8643
4 GRAPHIC g869071g32z30.jpg GRAPHIC 4461
5 GRAPHIC g869071g89y46.jpg GRAPHIC 2592
  Complete submission text file 0001193125-15-040615.txt   225067
Mailing Address 60 LEVERONI COURT NOVATO CA 94949
Business Address 60 LEVERONI COURT NOVATO CA 94949 415-483-8800
Ultragenyx Pharmaceutical Inc. (Filer) CIK: 0001515673 (see all company filings)

IRS No.: 272546083 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36276 | Film No.: 15590823
SIC: 2834 Pharmaceutical Preparations